Health
Antibody Cocktail Seems to Prevent COVID-19 Spread – Medscape
The antibody cocktail casirivimab and imdevimab may be an option to ward off infection, but the study didn’t quite reach statistical significance.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A one-time injection of the monoclonal antibody cocktail casirivimab with imdevimab (REGEN-COV), taken within 72 hours of a household member’s diagnosis with SARS-CoV-2, prevented 100% of COVID-19 illness, 100% of high SARS-CoV-2 viral loads, and cut length of asymptomatic infection to 1 week.
“It’s fantastic news,” said Rajesh Gandhi, MD, an infectious disease physician at Massachusetts General…
-
General20 hours agoSikh Lane a WA first as Dongara puts multicultural history on the map
-
General16 hours agoClick-bait Bandt | The Spectator Australia
-
General23 hours ago‘Prepare to leave’, residents told, after fire crews lose control of planned burn in central Victoria
-
General15 hours agoUS exempts smartphones, computers and other electronics from Donald Trump’s reciprocal tariffs